Skip to main content

TUESDAY 18TH APRIL 2023

Page 1

Buhari Recounts Achievements in Oil, Gas Sector, Lists PIA as Biggest Accomplishment Discloses N200bn, $7m raked in from sale of marginal fields Emmanuel Addeh in Abuja President Muhammadu Buhari yesterday attended the Nigeria

International Energy Summit (NIES), his last as the country’s leader, seizing the opportunity to highlight his administration’s

achievements in the sector from which Nigeria earns most of its foreign exchange. Speaking at the event in Abuja

Says $2.8bn AKK pipeline 43% completed

put together by Brevity Anderson, a Trade Advisory Consultancy specialised in strategic meetings, Buhari boasted that when he assumed office

in 2015, his administration set out to dismantle the challenges it met by embarking on major reforms. Buhari, who was represented by

the Secretary to the Government of the Federation (SGF), Mr. Boss Continued on page 10

Aviation Workers’ Strike Forces Passengers to Trek to Airport, Unions Block Access Roads... Page 6 Tuesday 18 April, 2023 Vol 28. No 10233. Price: N250

www.thisdaylive.com TR

UT H

& RE A S O

N

COVID-19: FG Effects N45.3bn Reimbursement to States, FCT... Page 5

NAFDAC Approves Clinical Malaria Vaccine for Children Onyebuchi Ezigbo in Abuja The National Agency for Food and Drug Administration and Control (NAFDAC) has granted registration approval for R21 Malaria Vaccine (Recombinant, Adjuvanted). The vaccine is manufactured

by Serum Institute of India Pvt. Ltd. (SIIPL). Director General of NAFDAC, Prof. Mojisola Adeyeye, who addressed journalists in Abuja, yesterday, said the vaccine was for prevention of clinical malaria in children from five months to

36 months of age. The storage temperature of the vaccine is 2-8 °C." She said: "NAFDAC in exercising its mandate as stipulated by its enabling law, NAFDAC Act CapN1, LFN 2004 is granting registration approval for R21 Malaria Vaccine (Recombinant, Adjuvanted)

manufactured by Serum Institute of India Pvt. Ltd. (SIIPL). “The Marketing Authorisation Holder’s (MAHs) is Fidson Healthcare Ltd in line with the Agency’s Drug and Related Products Registration Regulation 2021. "The R21 Malaria vaccine is

an Adjuvanted protein vaccine presented as a sterile solution. A dose which is 0.5ml is composed of R21 Malaria antigen 5μg and Matrix-M1 50μg as an adjuvant filled in a vial as ready to use liquid formulation for intramuscular injection.

"The vaccine is indicated for prevention of clinical malaria in children from 5 months to 36 months of age. The storage temperature of the vaccine is 2-8 °C." Adeyeye said R21 Malaria vaccine Continued on page 10

INEC Suspends Adamawa REC as Binani Seeks Judicial Review of Her Announcement

Story on page 10

PDP gives commission 72 hours ultimatum to conclude rerun poll Ari playing Yakubu’s script, Atiku’s aide alleges Party's govs forum commends electoral body for nullifying ‘attempted coup’ Demands weeding out of partisan, corrupt INEC officials

FOR A BETTER CIVIL SERVICE... Sitting: L-R: BSG, University of Oxford, Prof. Dapo Akande; Perm. Sec. FCT, Olusade Adesola; Perm. Sec, Fed Min of Water Resources, Esther Didi Walson-Jack; Prof. Chris Stone, BSG, University of Oxford; Head of Civil Service of the Federation, Dr. Folasade Yemi Esan; , Chairman, Aig-Imoukhuede Foundation, Aigboje Aig-Imoukhuede; BSG, University of Oxford, Eniola Soyemi; Perm. Sec, Fed. Min. of Communications, Dr. William Alo; Perm Sec Fed Min of Agriculture, Ernest Umakhihe; Perm. Sec, SGF Office, Dr. Nnamdi Maurice Mbaeri, and other serving Federal Permanent Secretaries at the AIG Senior Leaders Programme held in Abuja…recently


Turn static files into dynamic content formats.

Create a flipbook